説明

Fecal calprotectin levels, a marker of subclinical colonic inflammation, are compared between the anti-inflammatory diet and control diet groups over the study period in UC patients in remission.

Figure 3

Chart

Source Paper

Anti-Inflammatory Diet Prevents Subclinical Colonic Inflammation and Alters Metabolomic Profile of Ulcerative Colitis Patients in Clinical Remission.

Nutrients (2022)

PMID: 36014800

DOI: 10.3390/nu14163294

Cite This Figure

![Figure 3: Fecal calprotectin levels, a marker of subclinical colonic inflammation, are compared between the anti-inflammatory diet and control diet groups over the study period in UC patients in remission.]()

> Source: Ammar Hassanzadeh Keshteli et al. "Anti-Inflammatory Diet Prevents Subclinical Colonic Inflammation and Alters Meta." *Nutrients*, 2022. PMID: [36014800](https://pubmed.ncbi.nlm.nih.gov/36014800/)

<figure>
  <img src="" alt="Fecal calprotectin levels, a marker of subclinical colonic inflammation, are compared between the anti-inflammatory diet and control diet groups over the study period in UC patients in remission." />
  <figcaption>Figure 3. Fecal calprotectin levels, a marker of subclinical colonic inflammation, are compared between the anti-inflammatory diet and control diet groups over the study period in UC patients in remission.<br>  Source: Ammar Hassanzadeh Keshteli et al. "Anti-Inflammatory Diet Prevents Subclinical Colonic Inflammation and Alters Meta." <em>Nutrients</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36014800/">36014800</a></figcaption>
</figure>

説明

Figure 3

Source Paper

Cite This Figure

関連するエビデンス